An interventional study of Ultrasound-guided nerve hydrodissection in Carpal Tunnel Syndrome, sponsored by National Cheng-Kung University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-03-21.
Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Treatment
Carpal tunnel syndrome is the most common peripheral entrapment neuropathy of the upper limb. Previous experiments found that ultrasound-guided median nerve hydrodissection with 5% dextrose water could ameliorate the condition of carpal tunnel syndrome. Oral administration of vitamin B 12 had been reported to reduce the discomfort from peripheral neuropathy although the level of evidence is not strong. This prospective, double-blind randomized control trial aims to compare the effects of different kinds of the injection agents on carpal tunnel syndrome.
589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.
This study's planned enrollment of 120 is above the median of 60 across 445 interventional studies indexed under Carpal Tunnel Syndrome.
Browse Carpal Tunnel Syndrome studies →National Cheng-Kung University Hospital is the lead sponsor of 268 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Thoracic outlet syndrome
Procedure: Ultrasound-guided nerve hydrodissection
Procedure: Ultrasound-guided nerve hydrodissection
Procedure: Ultrasound-guided nerve hydrodissection
Peri- median nerve injection for hydrorelease and decompression
Change of Boston Carpal Tunnel Syndrome Questionnaire
Measure the severity of symptoms and functional status before and after treatment
Time frame: Pre-treatment, 1st, 3rd, 6th month after injection
Visual analog scale of pain and tingling
Measure the pain and tingling scale before treatment and after treatment. (0 is for not at all pain/tingling, and 100 is for extremely pain/tingling.)
Time frame: Pre-treatment, 1st, 3rd, 6th month after injection
Cross-sectional area of the median nerve
Using the ultrasound to measure the cross-sectional area of the median nerve before and after treatment
Time frame: Pre-treatment, 1st, 3rd, 6th month after injection
Median nerve elastography
Using the ultrasound to measure the elastography of the median nerve before and after treatment
Time frame: Pre-treatment, 1st, 3rd, 6th month after injection
Median nerve conduction velocity and amplitude
Antidromic sensory nerve conduction velocity and amplitude of the median nerve before and after treatment
Time frame: Pre-treatment, 1st, 6th month after injection
Plan to share: Yes
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cheng-Kung University Hospital